Skip to main content
. 2021 Apr 19;109(4):383–392. doi: 10.1007/s00223-021-00848-x

Fig. 2.

Fig. 2

Serum bone alkaline phosphatase (BAP) levels over time in non-responder patients and in those who experienced biochemical relapse after the first infusion of zoledronate. Data are represented as mean ± standard error of the mean. The arrows indicate the number of patients retreated after each time point